Epitalon vs Melanotan II
Overview
Epitalon is primarily a anti-aging & longevity peptide, while Melanotan II is used for cosmetic & skin.
This page compares Epitalon and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Epitalon | Melanotan II | |
|---|---|---|
| Category | Anti-aging & Longevity | Cosmetic & Skin |
| Regulatory status (US) | Not approved — Cat. 2 removed (Apr 2026) | Not approved — Cat. 2 removed (Apr 2026) |
| Typical dosage | 5-10 mg | — |
| Frequency | cycle | — |
| Reported benefits | Areas studied (research-reported, not established efficacy): telomerase activation and telomere elongation in human cell lines (PMID 12937682; DOI 10.1007/s10522-025-10315-x); increased melatonin synthesis and circadian effects in a small human study; lower overall and cardiovascular mortality in a 12-15 year single-lab trial that used pineal extract (epithalamin), not synthetic AEDG (PMID 17426848, 22451889). No independent multi-center RCTs; not FDA-approved. | Skin tanning without UV exposure, increased libido, potential appetite suppression |
| Reported side effects | Khavinson-group trials reported no serious adverse events (e.g., n=162 retinitis pigmentosa trial, PMID 12195242), but these are the only controlled safety data and remain unreplicated. Community use reports mild injection-site reactions. Theoretical concern: telomerase activation is a hallmark of most cancers, and a 2025 review (PMC11943447) notes carcinogenic potential is unstudied. No human pharmacokinetic or drug-interaction data. | Nausea, facial flushing, darkening of moles, potential cardiovascular effects |
Key differences
Primary use. Epitalon is categorised under Anti-aging & Longevity, while Melanotan II falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Epitalon: not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it. Melanotan II: not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Dosing. Epitalon is typically dosed at 5-10 mg (cycle). Typical dosing for Melanotan II is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking Epitalon and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Epitalon and Melanotan II?
- Epitalon is primarily a anti-aging & longevity peptide, while Melanotan II is used for cosmetic & skin. Epitalon is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it, whereas Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
- What is Epitalon used for?
- Longevity, telomere support.
- What is Melanotan II used for?
- Tanning, libido.
- Can you take Epitalon and Melanotan II together?
- Some users combine peptides within a single protocol, but stacking Epitalon and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Epitalon or Melanotan II FDA-approved?
- Epitalon is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it. Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Read the full articles
- Epitalon — full monograph: mechanism, research, dosing & references
- Melanotan II — full monograph: mechanism, research, dosing & references